slotkoers
Korea S.E.
00:00:00 21-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1.397
KRW
|
-8,75%
|
|
+36,29%
|
+23,63%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
91.801
|
76.579
|
59.310
|
131.317
|
48.354
|
38.524
|
Bedrijfswaarde
1 |
69.111
|
51.620
|
60.810
|
148.621
|
45.446
|
67.242
|
K/w-verhouding
|
-12,2
x
|
-195
x
|
-1,92
x
|
-3,67
x
|
-2,62
x
|
-2,72
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
5,98
x
|
2,04
x
|
4,55
x
|
5,1
x
|
0,62
x
|
0,4
x
|
Bedrijfswaarde/omzet
|
4,5
x
|
1,38
x
|
4,66
x
|
5,77
x
|
0,58
x
|
0,69
x
|
Bedrijfswaarde/EBITDA
|
-382
x
|
-21,4
x
|
-172
x
|
-31,7
x
|
-19,6
x
|
-52,5
x
|
Bedrijfswaarde/FCF
|
22,3
x
|
-2,28
x
|
3,59
x
|
-3,37
x
|
-5,85
x
|
-10,1
x
|
FCF Yield
|
4,49%
|
-43,8%
|
27,9%
|
-29,7%
|
-17,1%
|
-9,92%
|
Price to Book
|
3,16
x
|
1,71
x
|
1,57
x
|
2,84
x
|
1,71
x
|
2,41
x
|
Aantal aandelen (in duizenden)
|
10.955
|
12.936
|
16.475
|
32.344
|
32.344
|
34.092
|
Referentieprijs
2 |
8.380
|
5.920
|
3.600
|
4.060
|
1.495
|
1.130
|
Datum van publicatie
|
20/03/19
|
18/03/20
|
23/03/21
|
25/03/22
|
23/03/23
|
27/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
15.350
|
37.484
|
13.049
|
25.764
|
78.061
|
96.991
|
EBITDA
1 |
-180,7
|
-2.416
|
-353,6
|
-4.687
|
-2.316
|
-1.281
|
Bedrijfsresultaat (EBIT)
1 |
-751,2
|
-3.687
|
-834,6
|
-6.573
|
-8.803
|
-7.460
|
Operationele Marge
|
-4,89%
|
-9,84%
|
-6,4%
|
-25,51%
|
-11,28%
|
-7,69%
|
Resultaat voor belastingen (EBT)
1 |
-7.181
|
-4.598
|
-26.523
|
-31.836
|
-24.604
|
-20.047
|
Nettowinst (verlies)
1 |
-7.181
|
-367
|
-26.667
|
-29.489
|
-18.447
|
-13.813
|
Nettomarge
|
-46,78%
|
-0,98%
|
-204,35%
|
-114,46%
|
-23,63%
|
-14,24%
|
WPA
2 |
-684,1
|
-30,41
|
-1.875
|
-1.107
|
-570,4
|
-414,8
|
Free Cash Flow
1 |
3.100
|
-22.621
|
16.956
|
-44.105
|
-7.764
|
-6.669
|
FCF-marge
|
20,2%
|
-60,35%
|
129,94%
|
-171,19%
|
-9,95%
|
-6,88%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
20/03/19
|
18/03/20
|
23/03/21
|
25/03/22
|
23/03/23
|
27/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
1.500
|
17.304
|
-
|
28.718
|
Nettokaspositie
1 |
22.690
|
24.960
|
-
|
-
|
2.908
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-4,243
x
|
-3,692
x
|
-
|
-22,42
x
|
Free Cash Flow
1 |
3.100
|
-22.621
|
16.956
|
-44.105
|
-7.764
|
-6.669
|
ROE (netto-inkomsten/eigen vermogen)
|
-28,7%
|
-5,98%
|
-38,6%
|
-41,3%
|
-23,2%
|
-24,2%
|
ROA (netto-inkomsten/totale activa)
|
-1,26%
|
-2,41%
|
-0,51%
|
-3,38%
|
-3,14%
|
-2,53%
|
Totale activa
1 |
569.078
|
15.239
|
5.255.597
|
873.548
|
587.217
|
545.614
|
Nettoactief per aandeel
2 |
2.653
|
3.458
|
2.288
|
1.430
|
873,0
|
469,0
|
Cashflow per aandeel
2 |
3.056
|
4.104
|
487,0
|
1.044
|
1.489
|
1.176
|
Capex
1 |
526
|
1.491
|
1.707
|
22.180
|
5.635
|
17.658
|
Capex/omzet
|
3,42%
|
3,98%
|
13,08%
|
86,09%
|
7,22%
|
18,21%
|
Datum van publicatie
|
20/03/19
|
18/03/20
|
23/03/21
|
25/03/22
|
23/03/23
|
27/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +23,63% | 44,61 mln. | | +22,35% | 44,12 mld. | | +21,14% | 22,61 mld. | | +17,81% | 15,11 mld. | | +15,73% | 13,61 mld. | | +57,91% | 13,34 mld. | | -9,22% | 6,94 mld. | | -0,05% | 6,79 mld. | | +14,03% | 5,75 mld. | | -8,87% | 5,73 mld. |
Generieke geneesmiddelen
|